GFD-related improvement of PTH levels seem strictly related to the reversal of mucosal lesions, as hyperparathyroidism persists both in patients with refractory CD [10] and patients with a low compliance to GFD [18], and is associated with alterations of vitamin D metabolite levels [16]. This evidence concerns the gene PTH and hyperparathyroidism.